These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36839820)

  • 1. [
    Cheung P; Amin MA; Zhang B; Lechi F; Korsgren O; Eriksson J; Odell LR; Eriksson O
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ramatroban-Based Analogues Containing Fluorine Group as Potential
    Huang LA; Huang KX; Tu J; Kandeel F; Li J
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and preclinical evaluation of the CRTH2 antagonist [
    Eriksson J; Roy T; Sawadjoon S; Bachmann K; Sköld C; Larhed M; Weis J; Selvaraju RK; Korsgren O; Eriksson O; Odell LR
    Nucl Med Biol; 2019 Apr; 71():1-10. PubMed ID: 31082767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole-Based and Cyclopentenylindole-Based Analogues Containing Fluorine Group as Potential
    Yin R; Huang KX; Huang LA; Ji M; Zhao H; Li K; Gao A; Chen J; Li Z; Liu T; Shively JE; Kandeel F; Li J
    Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET Imaging of GPR44 by Antagonist [
    Cheung P; Zhang B; Puuvuori E; Estrada S; Amin MA; Ye S; Korsgren O; Odell LR; Eriksson J; Eriksson O
    Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33923731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR44 as a Target for Imaging Pancreatic Beta-Cell Mass.
    Eriksson O
    Curr Diab Rep; 2019 Jun; 19(8):49. PubMed ID: 31250117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-Step Automatic Radiosynthesis and Evaluation of [
    Peng J; Tang W; Rawson J; Miao L; Gonzalez N; Yin R; Chen J; Ji M; Li Z; Gao A; Wu AZ; Shively JE; Kandeel F; Li J
    Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of a GPR44 targeting radioligand [
    Jahan M; Johnström P; Selvaraju RK; Svedberg M; Winzell MS; Bernström J; Kingston L; Schou M; Jia Z; Skrtic S; Johansson L; Korsgren O; Farde L; Halldin C; Eriksson O
    EJNMMI Res; 2018 Dec; 8(1):113. PubMed ID: 30588560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR44 is a pancreatic protein restricted to the human beta cell.
    Hellström-Lindahl E; Danielsson A; Ponten F; Czernichow P; Korsgren O; Johansson L; Eriksson O
    Acta Diabetol; 2016 Jun; 53(3):413-21. PubMed ID: 26467464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Visualization of β-Cells by Targeting of GPR44.
    Eriksson O; Johnström P; Cselenyi Z; Jahan M; Selvaraju RK; Jensen-Waern M; Takano A; Sörhede Winzell M; Halldin C; Skrtic S; Korsgren O
    Diabetes; 2018 Feb; 67(2):182-192. PubMed ID: 29208633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Safety Evaluation and Human Dosimetry of [
    Koole M; Lohith TG; Valentine JL; Bennacef I; Declercq R; Reynders T; Riffel K; Celen S; Serdons K; Bormans G; Ferry-Martin S; Laroque P; Walji A; Hostetler ED; Briscoe RJ; de Hoon J; Sur C; Van Laere K; Struyk A
    Mol Imaging Biol; 2020 Feb; 22(1):173-180. PubMed ID: 31111397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the prostaglandin D
    Abadpour S; Tyrberg B; Schive SW; Huldt CW; Gennemark P; Ryberg E; Rydén-Bergsten T; Smith DM; Korsgren O; Skrtic S; Scholz H; Winzell MS
    Diabetologia; 2020 Jul; 63(7):1355-1367. PubMed ID: 32350565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.
    Skrtic S; Tyrberg B; Broberg M; Ericsson H; Schnecke V; Kjaer M; Hompesch M; Andersson EM; Ryberg E; Aivazidis A; Wennberg Huldt C; Löfgren L; Morrow L; Parkinson J; Rydén-Bergsten T; Watkins E; Sörhede Winzell M
    PLoS One; 2018; 13(12):e0208998. PubMed ID: 30557325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and monkey PET studies of [¹⁸F]MK-1312, a PET tracer for quantification of mGluR1 receptor occupancy by MK-5435.
    Hostetler ED; Eng W; Joshi AD; Sanabria-Bohórquez S; Kawamoto H; Ito S; O'Malley S; Krause S; Ryan C; Patel S; Williams M; Riffel K; Suzuki G; Ozaki S; Ohta H; Cook J; Burns HD; Hargreaves R
    Synapse; 2011 Feb; 65(2):125-35. PubMed ID: 20524178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of [¹⁸F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human.
    Hostetler ED; Sanabria-Bohórquez S; Eng W; Joshi AD; Patel S; Gibson RE; O'Malley S; Krause SM; Ryan C; Riffel K; Bi S; Okamoto O; Kawamoto H; Ozaki S; Ohta H; de Groot T; Bormans G; Depré M; de Hoon J; De Lepeleire I; Reynders T; Cook JJ; Burns HD; Egan M; Cho W; van Laere K; Hargreaves RJ
    Neuroimage; 2013 Mar; 68():1-10. PubMed ID: 23238431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.
    Burns HD; Van Laere K; Sanabria-Bohórquez S; Hamill TG; Bormans G; Eng WS; Gibson R; Ryan C; Connolly B; Patel S; Krause S; Vanko A; Van Hecken A; Dupont P; De Lepeleire I; Rothenberg P; Stoch SA; Cote J; Hagmann WK; Jewell JP; Lin LS; Liu P; Goulet MT; Gottesdiener K; Wagner JA; de Hoon J; Mortelmans L; Fong TM; Hargreaves RJ
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9800-5. PubMed ID: 17535893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).
    Wängler B; Schneider S; Thews O; Schirrmacher E; Comagic S; Feilen P; Schwanstecher C; Schwanstecher M; Shiue CY; Alavi A; Höhnemann S; Piel M; Rösch F; Schirrmacher R
    Nucl Med Biol; 2004 Jul; 31(5):639-47. PubMed ID: 15219283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.